CASP14 and laryngeal squamous cell carcinoma: Its upregulation reduced cell viability in cisplatin-resistant tongue and larynx squamous cell carcinoma cell lines by downregulating the genes for aquaporin-3 (AQP3), caspase-14 (CASP-14) and arachidonate 12R-lipoxygenase (ALOX12B) [24].